Ability of Recombinant Human Catalase to Suppress Inflammation of the Murine Lung Induced by Influenza A

作者：Shi Xunlong; Shi Zhihui; Huang Hai; Zhu Hongguang; Zhou Pei; Zhu Haiyan^*; Ju Dianwen

来源：Inflammation, 2014, 37(3): 809-817.

DOI：10.1007/s10753-013-9800-2

• catalase
• influenza
• pneumonia
• oxidative stress
• inflammation response

Influenza A virus pandemics and emerging antiviral resistance highlight the urgent need for novel generic pharmacological strategies that reduce both viral replication and inflammation of the lung. We have previously investigated the therapeutic efficacy of recombinant human catalase (rhCAT) against viral pneumonia in mice, but the protection mechanisms involved were not explored. In the present study, we have performed a more in-depth analysis covering survival, lung inflammation, immune cell responses, production of cytokines, and inflammation signaling pathways in mice. Male imprinting control region mice were infected intranasally with high pathogenicity (H1N1) influenza A virus followed by treatment with recombinant human catalase. The administration of rhCAT resulted in a significant reduction in inflammatory cell infiltration (e.g., macrophages and neutrophils), inflammatory cytokine levels (e.g., IL-2, IL-6, TNF-alpha, IFN-gamma), the level of the intercellular adhesion molecule 1 chemokine and the mRNA levels of toll-like receptors TLR-4, TLR-7, and NF-kappa B, as well as partially maintaining the activity of the antioxidant enzymes system. These findings indicated that rhCAT might play a key protective role in viral pneumonia of mice via suppression of inflammatory immune responses.

• 出版日期2014-6
• 单位复旦大学